♥
ISIN : INE123W01016
NSE : SBILIFE
BSE : 540719
Face Value : 10
Industry : Insurance
EPS : 18.90
EPS (TTM) : 21.76
Price to Earning (P/E) : 81.90
Book Value : 145.68
Price to Bookvalue (P/B) : 10.63
Dividend Yield : 0 %
Return on Equity (ROE) : 13.77 %
Return on Capital Employed (ROCE) : 14.12 %
SBI Life Insurance Company Limited
ISIN : INE123W01016
NSE : SBILIFE
BSE : 540719
Face Value : 10
Industry : Insurance
EPS : 18.90
EPS (TTM) : 21.76
Price to Earning (P/E) : 81.90
Book Value : 145.68
Price to Bookvalue (P/B) : 10.63
Dividend Yield : 0 %
Return on Equity (ROE) : 13.77 %
Return on Capital Employed (ROCE) : 14.12 %
SBI Life share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 1783.05 - 1773.75 -0.5 % |
| Low / High | 1730 - 1783.05 3.1 % |
| Trade Volume | 30,808 |
| 52 Week Low / High | 1663.2 - 2132.9 28.2 % |
-
YOU MAY ALSO LIKE
- Share Market basics for beginners
Share Market jargons in simple terms - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - Stock market course tutorial
Stock Market Investment Course explained in simple words. - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
CONSOLIDATED QUARTERLY RESULT FOR SBI LIFE INSURANCE COMPANY LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 110360 | 164773 | 191708 | 198969 | 131045 | 200497 | 223165 | 251165 | 151055 | 202661 |
| Total Income | 48172.9 | 277285 | 268298 | 230182 | 279040 | 288162 | 390508 | 378945 | 346570 | 402976 |
| Total Expenditure | 45164.3 | 272915 | 264833 | 221967 | 274714 | 283921 | 386808 | 370434 | 340600 | 396962 |
| Other Income | -62187.3 | 112512 | 76589.7 | 31213.1 | 147995 | 87665 | 167343 | 127780 | 195515 | 200315 |
| Operating Profit | 3008.6 | 4369.5 | 3464.8 | 8215.5 | 4326.4 | 4240.8 | 3699.5 | 8511.3 | 5969.8 | 6014.4 |
| PBDT | 3008.6 | 4369.5 | 3464.8 | 8215.5 | 4326.4 | 4240.8 | 3699.5 | 8511.3 | 5969.8 | 6014.4 |
| Profit Before Tax | 3008.6 | 4369.5 | 3464.8 | 8215.5 | 4326.4 | 4240.8 | 3699.5 | 8511.3 | 5969.8 | 6014.4 |
| Tax | 380.1 | 602.1 | 423.5 | 447 | 516 | 438.9 | 482 | 403.3 | 774.6 | 720.2 |
| Profit After Tax | 2628.5 | 3767.4 | 3041.3 | 7768.5 | 3810.4 | 3801.9 | 3217.5 | 8108 | 5195.2 | 5294.2 |
| Net Profit | 2628.5 | 3767.4 | 3041.3 | 7768.5 | 3810.4 | 3801.9 | 3217.5 | 8108 | 5195.2 | 5294.2 |
| Equity Capital | 10004.8 | 10007.1 | 10008.3 | 10008.9 | 10009.7 | 10010.9 | 10012.4 | 10014.7 | 10015.8 | 10019.2 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 106879 | 110801 | 113925 | 119237 | 123097 | 126990 | 130327 | 135900 | 141181 | 146776 |
| Calculated EPS | 2.63 | 3.76 | 3.04 | 7.76 | 3.81 | 3.8 | 3.21 | 8.1 | 5.19 | 5.28 |
| Diluted Eps After Extraordinary Items | 2.63 | 3.76 | 3.04 | 7.76 | 3.8 | 3.79 | 3.21 | 8.09 | 5.18 | 5.28 |
| Diluted Eps Before Extraordinary Items | 2.63 | 3.76 | 3.04 | 7.76 | 3.8 | 3.79 | 3.21 | 8.09 | 5.18 | 5.28 |
STANDALONE QUARTERLY RESULT FOR SBI LIFE INSURANCE COMPANY LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 110360 | 164773 | 191708 | 198969 | 131045 | 200497 | 223165 | 251165 | 151055 | 202661 |
| Total Income | 48172.9 | 277285 | 268298 | 230182 | 279040 | 288162 | 390508 | 378945 | 346570 | 402976 |
| Total Expenditure | 45164.3 | 272915 | 264833 | 221967 | 274714 | 283921 | 386808 | 370434 | 340600 | 396962 |
| Other Income | -62187.3 | 112512 | 76589.7 | 31213.1 | 147995 | 87665 | 167343 | 127780 | 195515 | 200315 |
| Operating Profit | 3008.6 | 4369.5 | 3464.8 | 8215.5 | 4326.4 | 4240.8 | 3699.5 | 8511.3 | 5969.8 | 6014.4 |
| PBDT | 3008.6 | 4369.5 | 3464.8 | 8215.5 | 4326.4 | 4240.8 | 3699.5 | 8511.3 | 5969.8 | 6014.4 |
| Profit Before Tax | 3008.6 | 4369.5 | 3464.8 | 8215.5 | 4326.4 | 4240.8 | 3699.5 | 8511.3 | 5969.8 | 6014.4 |
| Tax | 380.1 | 602.1 | 423.5 | 447 | 516 | 438.9 | 482 | 403.3 | 774.6 | 720.2 |
| Profit After Tax | 2628.5 | 3767.4 | 3041.3 | 7768.5 | 3810.4 | 3801.9 | 3217.5 | 8108 | 5195.2 | 5294.2 |
| Net Profit | 2628.5 | 3767.4 | 3041.3 | 7768.5 | 3810.4 | 3801.9 | 3217.5 | 8108 | 5195.2 | 5294.2 |
| Equity Capital | 10004.8 | 10007.1 | 10008.3 | 10008.9 | 10009.7 | 10010.9 | 10012.4 | 10014.7 | 10015.8 | 10019.2 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 106879 | 110801 | 113925 | 119237 | 123097 | 126990 | 130327 | 135900 | 141181 | 146776 |
| Calculated EPS | 2.63 | 3.76 | 3.04 | 7.76 | 3.81 | 3.8 | 3.21 | 8.1 | 5.19 | 5.28 |
| Diluted Eps After Extraordinary Items | 2.63 | 3.76 | 3.04 | 7.76 | 3.8 | 3.79 | 3.21 | 8.09 | 5.18 | 5.28 |
| Diluted Eps Before Extraordinary Items | 2.63 | 3.76 | 3.04 | 7.76 | 3.8 | 3.79 | 3.21 | 8.09 | 5.18 | 5.28 |
CONSOLIDATED ANNUAL RESULT FOR SBI LIFE INSURANCE COMPANY LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 584323 | 665810 | 805871 |
| Total Income | 830335 | 823937 | 1336650 |
| Total Expenditure | 813466 | 804879 | 1315880 |
| Other Income | 246012 | 158127 | 530784 |
| Operating Profit | 16869.1 | 19058.4 | 20777.9 |
| PBDT | 16869.1 | 19058.4 | 20777.9 |
| Profit Before Tax | 16869.1 | 19058.4 | 20777.9 |
| Tax | 1809.2 | 1852.7 | 1840.1 |
| Profit After Tax | 15059.9 | 17205.7 | 18937.8 |
| Net Profit | 15059.9 | 17205.7 | 18937.8 |
| Equity Capital | 10003.7 | 10008.9 | 10014.7 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 104181 | 119237 | 135900 |
| Calculated EPS | 15.05 | 17.19 | 18.91 |
| Diluted Eps After Extraordinary Items | 15.04 | 17.18 | 18.9 |
| Diluted Eps Before Extraordinary Items | 15.04 | 17.18 | 18.9 |
STANDALONE ANNUAL RESULT FOR SBI LIFE INSURANCE COMPANY LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 584323 | 665810 | 805871 |
| Total Income | 830335 | 823937 | 1336650 |
| Total Expenditure | 813466 | 804879 | 1315880 |
| Other Income | 246012 | 158127 | 530784 |
| Operating Profit | 16869.1 | 19058.4 | 20777.9 |
| PBDT | 16869.1 | 19058.4 | 20777.9 |
| Profit Before Tax | 16869.1 | 19058.4 | 20777.9 |
| Tax | 1809.2 | 1852.7 | 1840.1 |
| Profit After Tax | 15059.9 | 17205.7 | 18937.8 |
| Net Profit | 15059.9 | 17205.7 | 18937.8 |
| Equity Capital | 10003.7 | 10008.9 | 10014.7 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 104181 | 119237 | 135900 |
| Calculated EPS | 15.05 | 17.19 | 18.91 |
| Diluted Eps After Extraordinary Items | 15.04 | 17.18 | 18.9 |
| Diluted Eps Before Extraordinary Items | 15.04 | 17.18 | 18.9 |
CONSOLIDATED PROFIT / LOSS FOR SBI LIFE INSURANCE COMPANY LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
STANDALONE PROFIT / LOSS FOR SBI LIFE INSURANCE COMPANY LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
CONSOLIDATED CASH FLOW FOR SBI LIFE INSURANCE COMPANY LIMITED
STANDALONE CASH FLOW FOR SBI LIFE INSURANCE COMPANY LIMITED
CONSOLIDATED BALANCE SHEET FOR SBI LIFE INSURANCE COMPANY LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
STANDALONE BALANCE SHEET FOR SBI LIFE INSURANCE COMPANY LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|
FINANCIAL RATIOS (CONSOLIDATED) FOR SBI LIFE INSURANCE COMPANY LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 14.56 | 15.05 | 17.19 | 18.91 |
| CEPS(Rs) | 14.56 | 15.05 | 17.19 | 18.91 |
| DPS(Rs) | 2.5 | 2 | 2.5 | 2.7 |
| Book NAV/Share(Rs) | 100.92 | 114.13 | 129.11 | 145.68 |
| Tax Rate(%) | 6.32 | 8.08 | 8.38 | 6.99 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | -61.11 | -38.65 | -18.04 | -60.95 |
| EBIT Margin(%) | 3.1 | 2.67 | 2.64 | 2.41 |
| Pre Tax Margin(%) | 3.1 | 2.67 | 2.64 | 2.41 |
| PAT Margin (%) | 2.93 | 2.58 | 2.58 | 2.35 |
| Cash Profit Margin (%) | 2.93 | 2.58 | 2.58 | 2.35 |
| Performance Ratios | ||||
| ROA(%) | 0.76 | 0.61 | 0.6 | 0.54 |
| ROE(%) | 15.34 | 14 | 14.14 | 13.77 |
| ROCE(%) | 16.26 | 14.51 | 14.45 | 14.12 |
| Asset Turnover(x) | 0.26 | 0.24 | 0.23 | 0.23 |
| Sales/Fixed Asset(x) | 43.78 | 49.25 | 54.8 | 64.44 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.02 | 0.02 | 0.02 | 0.02 |
| Valuation Parameters | ||||
| PER(x) | 60.48 | 74.41 | 63.97 | 79.21 |
| PCE(x) | 60.48 | 74.41 | 63.97 | 79.21 |
| Price/Book(x) | 8.73 | 9.82 | 8.52 | 10.28 |
| Yield(%) | 0.28 | 0.18 | 0.23 | 0.18 |
| EV/Net Sales(x) | 1.71 | 1.86 | 1.59 | 1.8 |
| EV/Core EBITDA(x) | 44.8 | 54.16 | 35.26 | 49.63 |
| EV/EBIT(x) | 55.33 | 69.75 | 60.22 | 74.8 |
| EV/CE(x) | 0.38 | 0.41 | 0.34 | 9.96 |
| M Cap / Sales | 1.77 | 1.92 | 1.65 | 1.86 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 23.42 | 17.41 | 13.95 | 21.04 |
| Core EBITDA Growth(%) | -16.13 | 5.51 | 49.44 | -2.55 |
| EBIT Growth(%) | 9.12 | 1.19 | 12.67 | 10.44 |
| PAT Growth(%) | 2.37 | 3.44 | 14.25 | 10.07 |
| EPS Growth(%) | 2.36 | 3.41 | 14.19 | 10 |
| Financial Stability Ratios | ||||
| Current Ratio(x) | 1.69 | 1.48 | 1.61 | 1.8 |
| Quick Ratio(x) | 1.69 | 1.48 | 1.61 | 1.8 |
FINANCIAL RATIOS (STANDALONE) FOR SBI LIFE INSURANCE COMPANY LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 14.56 | 15.05 | 17.19 | 18.91 |
| CEPS(Rs) | 14.56 | 15.05 | 17.19 | 18.91 |
| DPS(Rs) | 2.5 | 2 | 2.5 | 2.7 |
| Book NAV/Share(Rs) | 100.92 | 114.13 | 129.11 | 145.68 |
| Tax Rate(%) | 6.32 | 8.08 | 8.38 | 6.99 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | -61.11 | -38.65 | -18.04 | -60.95 |
| EBIT Margin(%) | 3.1 | 2.67 | 2.64 | 2.41 |
| Pre Tax Margin(%) | 3.1 | 2.67 | 2.64 | 2.41 |
| PAT Margin (%) | 2.93 | 2.58 | 2.58 | 2.35 |
| Cash Profit Margin (%) | 2.93 | 2.58 | 2.58 | 2.35 |
| Performance Ratios | ||||
| ROA(%) | 0.76 | 0.61 | 0.6 | 0.54 |
| ROE(%) | 15.34 | 14 | 14.14 | 13.77 |
| ROCE(%) | 16.26 | 14.51 | 14.45 | 14.12 |
| Asset Turnover(x) | 0.26 | 0.24 | 0.23 | 0.23 |
| Sales/Fixed Asset(x) | 43.78 | 49.25 | 54.8 | 64.44 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.02 | 0.02 | 0.02 | 0.02 |
| Valuation Parameters | ||||
| PER(x) | 60.48 | 74.41 | 63.97 | 79.21 |
| PCE(x) | 60.48 | 74.41 | 63.97 | 79.21 |
| Price/Book(x) | 8.73 | 9.82 | 8.52 | 10.28 |
| Yield(%) | 0.28 | 0.18 | 0.23 | 0.18 |
| EV/Net Sales(x) | 1.71 | 1.86 | 1.59 | 1.8 |
| EV/Core EBITDA(x) | 44.8 | 54.16 | 35.26 | 49.63 |
| EV/EBIT(x) | 55.33 | 69.75 | 60.22 | 74.8 |
| EV/CE(x) | 0.38 | 0.41 | 0.34 | 9.96 |
| M Cap / Sales | 1.77 | 1.92 | 1.65 | 1.86 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 23.42 | 17.41 | 13.95 | 21.04 |
| Core EBITDA Growth(%) | -16.13 | 5.51 | 49.44 | -2.55 |
| EBIT Growth(%) | 9.12 | 1.19 | 12.67 | 10.44 |
| PAT Growth(%) | 2.37 | 3.44 | 14.25 | 10.07 |
| EPS Growth(%) | 2.36 | 3.41 | 14.19 | 10 |
| Financial Stability Ratios | ||||
| Current Ratio(x) | 1.69 | 1.48 | 1.61 | 1.8 |
| Quick Ratio(x) | 1.69 | 1.48 | 1.61 | 1.8 |
SHARE HOLDING PATTERN FOR SBI LIFE INSURANCE COMPANY LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 55.48 | 55.46 | 55.45 | 55.45 | 55.45 | 55.44 | 55.43 | 55.42 | 55.41 | 55.39 |
| FII % | 23.90 | 24.33 | 25.09 | 25.14 | 26.22 | 26.18 | 25.92 | 25.16 | 24.70 | 25.18 |
| DII % | 0.31 | 0.31 | 0.24 | 0.32 | 0.36 | 0.36 | 0.37 | 0.37 | 0.47 | 0.53 |
| Public % | 8.33 | 4.56 | 4.52 | 4.33 | 4.18 | 4.10 | 4.02 | 4.01 | 3.99 | 4.10 |
PEER COMPARISON FOR SBI LIFE INSURANCE COMPANY LIMITED
CORPORATE ACTIONS FOR SBI LIFE
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 15-Oct-2024 | Board Meeting - Quarterly Results & Audited Results | 23-Oct-2024 |
| BSE 11-Jul-2024 | Board Meeting - Quarterly Results & Audited Results | 24-Jul-2024 |
| BSE 12-Apr-2024 | Board Meeting - Audited Results | 26-Apr-2024 |
| BSE 15-Mar-2024 | Dividend - Interim Dividend | |
| BSE 05-Mar-2024 | Board Meeting - Interim Dividend | 10-Mar-2024 |
| BSE 11-Jan-2024 | Board Meeting - Quarterly Results | 25-Jan-2024 |
| BSE 17-Oct-2023 | Board Meeting - Quarterly Results & Audited Results | 27-Oct-2023 |
| BSE 07-Jul-2023 | Board Meeting - Quarterly Results | 25-Jul-2023 |
| BSE 10-Apr-2023 | Board Meeting - Audited Results | 26-Apr-2023 |
| BSE 16-Mar-2023 | Dividend - Interim Dividend | |
| BSE 02-Mar-2023 | Board Meeting - Interim Dividend | 08-Mar-2023 |
| BSE 05-Jan-2023 | Board Meeting - Quarterly Results | 21-Jan-2023 |
| BSE 07-Oct-2022 | Board Meeting - Quarterly Results | 21-Oct-2022 |
| BSE 28-Jul-2022 | AGM - Inter alia, approved: 1. The 22nd Annual General Meeting of the Company will be held on Monday, August 29, 2022 at 12:00 P.M. through Video Conference (VC)/ Other Audio-Visual Means (OAVM) facility and without the physical presence of the shareholders at a common venue. Other relevant details are being provided in the notice of AGM, which will be issued in due course. 2. Alteration of Article of A... | 29-Aug-2022 |
| BSE 18-Jul-2022 | Board Meeting - Quarterly Results | 28-Jul-2022 |
| BSE 18-Apr-2022 | Board Meeting - Audited Results | 28-Apr-2022 |
| BSE 29-Mar-2022 | Dividend - Interim Dividend | |
| BSE 15-Mar-2022 | Board Meeting - Interim Dividend | 22-Mar-2022 |
| BSE 13-Jan-2022 | Board Meeting - Quarterly Results | 21-Jan-2022 |
| BSE 18-Oct-2021 | Board Meeting - Quarterly Results | 27-Oct-2021 |
CORPORATE ANNOUNCEMENTS FOR SBI LIFE
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 30-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Earnings Call Transcript The transcript of the earnings call held on Wednesday October 23 2024 with analysts/investors is enclosed for Q2 for the FY 2024-25. The same is also hosted on the Companys website. |
| BSE 23-Oct-2024 | General Announcements FILE | Audio Recording - Earnings Call For Q2 Of FY 2024-25 Audio recording of the earnings conference call with analysts or institutional investors held on October 23 2024 w.r.t. financial results of the Company for the quarter and half year ended September 30 2024 has been hosted on the Companys website. |
| BSE 23-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release A copy of the press release and investor presentation being issued in connection with the performance of the Company for the quarter and half year ended September 30 2024 is enclosed. The above information is also made available on the Companys website www.sbilife.co.in |
| BSE 23-Oct-2024 | Outcome FILE | Audited Financial Results For The Quarter And Half Year Ended September 30 2024 We wish to inform yo that the meeting of the Board of Directors of the Company commenced at 11.40 AM and concluded at 2.30 PM on October 23 2024 which inter alia approved the Audited Financial Results for the quarter and half year ended September 30 2024. |
| BSE 23-Oct-2024 | Outcome FILE | Board Meeting Outcome for Outcome Of The Board Meeting Held On October 23 2024 We wish to inform you that the Meeting of the Board of Directors of the Company commenced at 11:40 am and concluded at 2:30 pm on October 23 2024 which inter-alia approved the Audited Financial Results for the quarter and half year ended September 30 2024 |
| BSE 19-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation The Company will be hosting an earnings conference call with analysts and investors at 16:15 (IST) on October 23 2024 to update the performance of the Company for the half year ended September 30 2024.An audio recording and transcript of the earnings call will be hosted on the Companys website at www.sbilife.co.in |
| BSE 15-Oct-2024 | Intimation FILE | Board Meeting Intimation for Considering And Approving Audited Financial Results For The Quarter Ended September 30 2024 SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve audited financial results for the quarter & half year ended September 30 2024.The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations.Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated September 26 2024 bearing reference number SBIL/CS/NSE-BSE/2425/147 the trading window is closed from October 01 2024 and will reopen 48 hours after the declaration of audited financial results for the quarter & half year ended September 30 2024. |
| BSE 11-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s We wish to inform you that the Company is in receipt of the Communication on October 11 2024 from the Comptroller & Auditor General of India (C&AG) pertaining to appointment of Joint Statutory Auditors for the Financial year 2024-25. The Office of C&AG has appointed M/s K. S. Aiyar & Co. in place of M/s G. M. Kapadia & Co. as the Joint Statutory Auditor of the Company. The Joint Statutory Auditors of the Company for the Financial Year for 2024-25 are as follows: 1. M/s. John Moris & Co. 2. M/s. K. S. Aiyar & Co. |
| BSE 10-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2024. |
| BSE 01-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s We wish to inform you that the Company is in receipt of the communication on October 01 2024 from the Comptroller & Auditor General of India (C&AG) pertaining to appointment of Joint Statutory Auditors for the Financial year 2024-25. The Office of the C&AG has appointed the following firm of the Chartered Accountants as the Joint Statutory Auditors of the Company: 1. M/s A John Moris & Co. 2. M/s. G.M. Kapadia & Co. |
| BSE 26-Sep-2024 | Intimation FILE | Closure of Trading Window Please note that the trading window to deal in securities of the Company will remain closed from October 01 2024 till 48 hours after the declaration of audited financial results for the quarter & half year ended September 30 2024 |
| BSE 23-Sep-2024 | General Announcements FILE | Cancellation Of Investor/ Analyst Meet With reference to our letter dated September 10 2024 & September 18 2024 respectively and pursuant to regulations 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 we wish to inform you that our group investor meet hosted by J.P Morgans India Investor Summit on September 23 2024 has been cancelled |
| BSE 20-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Senior Management of the Company had Analyst(s)/ Investor(s) meeting on September 20 2024. |
| BSE 18-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation With reference to our letter dated September 10 2024 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that our group investor meet hosted by J.P. Morgans India Investor Summit on September 24 2024 has been rescheduled to September 23 2024. |
| BSE 18-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Senior Management of the Company had Analyst(s)/ Investor(s) meeting on September 18 2024. |
| BSE 17-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation The Senior Management of the Company intends to interact with Investor(s)/analyst(s). The schedule of the meeting (s) is subject to change and hence the final schedule including the list of investors will be published once the meeting is concluded. Please note that no unpublished price sensitive information will be shared during the meeting(s). |
| BSE 17-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS The Board Stakeholders Relationship & Sustainability Committee vide its resolution passed on September 17 2024 has allotted 1 35 353 Equity shares of Rs. 10/- each towards the exercise of vested stock options. |
| BSE 13-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Senior Management of the Company had Analyst(s)/Investor(s) meeting on September 13 2024 |
| BSE 10-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation The Senior Management of the Company intends to interact with investor(s)/analyst(s). The schedule of the meeting(s) is subject to change and hence the final schedule including the list of investors will be published once the meetings are concluded. Please note that no unpublished price sensitive information shall be shared during the meeting. |
| BSE 07-Sep-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") Pursuant to Regulations 30 of the Listing Regulations this is to inform that Insurance Regulatory and Development Authority of India ("IRDAI:/ "The Authority") had conducted an onsite inspection of the Company in month of October 2020 for the period from FY 2017-18 to FY 2019-20.Subsequently the Authority issued the show cause notice on June 20 2024 and provided an opportunity for personal hearing and additional submissions. Post the detailed submission made by the Company and personal hearing the Authority has issued an advisory and levied a penalty amounting Rs. One crore.The details as required under Regulation 30 read with the Para A of Part A of Schedule III of the Listing Regulations is enclosed as Annexure - A |
| BSE 31-Aug-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 This is to inform that the Company has received an order under Section 73 of the MPGST and CGST Act 2017 from the Joint Commissioner CGST & Central Excise Bhopal Madhya Pradesh on August 31 2024 at 05:07 P.M. |
| BSE 31-Aug-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 This is to inform that the Company has received an order under Section 73 of the BGST and CGST Act 2017 from the Deputy Commissioner of State tax Patna Special Central Bihar on August 30 2024 at 9:20 P.M. |
| BSE 30-Aug-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 This is to inform that the Company has received an order under Section 73 of the KSGST and CGST Act 2017 from the Superintendent CGST Pattom Range Kerala on August 30 2024 at 1:34 A.M. |
| BSE 28-Aug-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 This is inform you that the Company has received an order under Section-73 of the JGST and CGST Act 2017 from the State Tax Officer Ranchi West Ranchi Jharkhand on August 28 2024 at 04:54 PM |
| BSE 28-Aug-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 This is to inform that the Company has received an order under Section 73 of the CGGST and CGST Act 2017 from the Deputy Commissioner of State tax Raipur Division-1 Chattisgarh on August 28 2024 at 5:33 pm. |
| BSE 28-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Please find attached Voting Results and Scrutinizers Report of the 24th AGM held on August 26 2024 |
| BSE 28-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Directorate We wish to inform the exchanges that Mr. Dinesh Kumar Khara (DIN: 06737041) has demitted the office of Chairman of State Bank of India from the close of business of August 27 2024 on account of his completion of term as the Chairman of the State Bank of India.Mr. Dinesh Kumar Khara has tendered his resignation as a Non-Executive Nominee Director of SBI Life Insurance Company Limited ("Company") consequently he ceases to be the Chairman of the Company. |
| BSE 26-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Please find attached proceedings of the 24th Annual General Meeting held on August 26 2024 |
| BSE 26-Aug-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 This is to inform that the Company has received an order under Section 73 of the TNGST and CGST Act 2017 from the Deputy Commissioner (CT) LTU-DC3 Chennai Tamilnadu on August 26 2024 at 9.02 A.M. |
| BSE 26-Aug-2024 | General Announcements FILE | Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 This is to inform that the Company has received an order under Section 73 of the WBGST and CGST Act 2017 from the Deputy Commissioner Large Tax Payer Unit Corporate Division West Bengal on August 26 2024 at 8.51 A.M. |
INSIDER TRADING FOR SBI LIFE
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 22-Feb-2022 23-Feb-2022 | Sell Market | 2,003,610 @ 0.00 (0.00 %) | BNP Paribas Cardif |
BULK BLOCK DEALS FOR SBI LIFE INSURANCE COMPANY LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 29-Feb-2024 | Sell BLOCK | 2,078,840 @ 1534.30 | BNP PARIBAS ARBITRAGE |
| BSE 29-Feb-2024 | Buy BLOCK | 2,078,840 @ 1534.30 | EAST BRIDGE CAPITAL MASTER FUND I LTD |
| BSE 21-Feb-2024 | Sell BLOCK | 317,727 @ 1513.45 | JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED |
| BSE 21-Feb-2024 | Buy BLOCK | 317,727 @ 1513.45 | THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT |
| BSE 17-Oct-2022 | Sell BLOCK | 612,123 @ 1179.80 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 17-Oct-2022 | Buy BLOCK | 612,123 @ 1179.80 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 11-Oct-2022 | Sell BLOCK | 598,564 @ 1239.30 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 11-Oct-2022 | Buy BLOCK | 598,564 @ 1239.30 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 19-Sep-2022 | Sell BLOCK | 407,137 @ 1272.25 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 19-Sep-2022 | Buy BLOCK | 407,137 @ 1272.25 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 01-Aug-2022 | Sell BLOCK | 531,662 @ 1294.40 | ISHARES INDIA INDEX MAURITIUS COMPANY |
| BSE 01-Aug-2022 | Buy BLOCK | 531,662 @ 1294.40 | ISHARES MSCI INDIA ETF |
| BSE 18-Jul-2022 | Buy BLOCK | 70,298 @ 1155.45 | ISHARES INDIA 50 ETF |
| BSE 18-Jul-2022 | Sell BLOCK | 534,857 @ 1155.45 | ISHARES INDIA INDEX MAURITIUS COMPANY |
| BSE 18-Jul-2022 | Sell BLOCK | 70,298 @ 1155.45 | ISHARES INDIA MAURITIUS CO |
| BSE 18-Jul-2022 | Buy BLOCK | 534,857 @ 1155.45 | ISHARES MSCI INDIA ETF |
| BSE 04-May-2022 | Buy BLOCK | 477,939 @ 1081.05 | ISHARES CORE MSCI TOTAL INTERNATIONAL STOCK ETF |
| BSE 04-May-2022 | Sell BLOCK | 477,939 @ 1081.05 | ISHARES CORE TOTAL INTERNATIONAL STOCK MAURITIUS CO |
| BSE 20-Oct-2021 | Sell BLOCK | 412,159 @ 1193.45 | ISHARES EMERGING MARKETS INDEX MAURITIUS CO |
| BSE 20-Oct-2021 | Buy BLOCK | 412,159 @ 1193.45 | ISHARES MSCI EMERGING MARKETS ETF |
| BSE 11-Oct-2021 | Sell BLOCK | 412,159 @ 1196.45 | ISHARES EMERGING MARKETS INDEX MAURITIUS CO |
| BSE 11-Oct-2021 | Buy BLOCK | 412,159 @ 1196.45 | ISHARES MSCI EMERGING MARKETS ETF |
| BSE 23-Sep-2021 | Sell BLOCK | 419,521 @ 1191.30 | ISHARES EMERGING MARKETS INDEX MAURITIUS CO |
| BSE 23-Sep-2021 | Buy BLOCK | 419,521 @ 1191.30 | ISHARES MSCI EMERGING MARKETS ETF |
| BSE 09-Sep-2021 | Buy BULK | 9,635,692 @ 1171.00 | BNP PARIBAS ARBITRAGE |
| BSE 09-Sep-2021 | Sell BULK | 23,000,000 @ 1171.07 | CANADA PENSION PLAN INVESTMENT BOARD |
| BSE 31-Aug-2021 | Buy BLOCK | 170,961 @ 1180.70 | TEACHER RETIREMENT SYSTEM OF TEXAS |
| BSE 31-Aug-2021 | Sell BLOCK | 170,961 @ 1180.70 | TEACHER RETIREMENT SYSTEM OF TEXAS |
DIVIDEND BY SBI LIFE INSURANCE COMPANY LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 07-Mar-2025 | INTERIM DIVIDEND | 2.7 |
| 15-Mar-2024 | INTERIM DIVIDEND | 2.7 |
| 16-Mar-2023 | INTERIM DIVIDEND | 2.5 |
| 29-Mar-2022 | INTERIM DIVIDEND | 2 |
| 05-Apr-2021 | INTERIM DIVIDEND | 2.5 |
SPLIT / BONUS BY SBI LIFE INSURANCE COMPANY LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
